Application of Dendrobium officinale-derived exosome-like nano-vesicles in stimulation of polarization of macrophages into M2-type macrophages
By using exosome-like nanovesicles (DONVs) derived from Dendrobium officinale to stimulate macrophages to polarize into the M2 type, the problem of difficulty in effectively polarizing macrophages into anti-inflammatory macrophages in existing technologies was solved, thus achieving the effects of promoting tissue repair and reducing inflammation.
Patent Information
- Application Number
- CN202411039897.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2026-02-03
AI Technical Summary
Existing technologies are insufficient to effectively stimulate macrophages to polarize into M2-type macrophages with anti-inflammatory effects, thus affecting inflammation control and tissue repair processes.
Using exosome-like nanovesicles (DONVs) derived from Dendrobium officinale, we can promote autophagy activation by reducing ROS levels in macrophages, increasing the number of M2 macrophages, reducing the secretion of pro-inflammatory factors, and downregulating genes related to the C-type lectin receptor pathway to activate the NF-κB pathway.
It effectively polarizes macrophages to the M2 type, reduces the secretion of pro-inflammatory factors, promotes tissue repair, reduces inflammatory response, and enhances the anti-inflammatory effect of macrophages.
Smart Images

Figure CN121450580A_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The present application relates to the application of exosome-like nanovesicles derived from Dendrobium officinale in stimulating macrophages to polarize into M2 type macrophages, and belongs to the technical field of biotechnology. BACKGROUND
[0003] Inflammation is an important and complex combined response of the body, and the occurrence of inflammation is caused by physical or chemical stimulation of the stimulating site, which triggers an immune response and aggregates immune cells. Macrophages are an important type of immune cells, mainly responsible for the uptake and digestion of foreign bodies, bacteria and dead cells in the body. The regulation of the activity and number of macrophages plays a key role in the control and resolution of inflammation. Macrophages are cells in the innate immune system, present in almost all tissues, with multiple functions, the main function being to phagocytose cell debris and pathogens in the form of fixed cells or free cells. Macrophages are an important cell in inflammation-related processes, which can be polarized into different phenotypes in different environments. In the process of inflammation, macrophages play an important role, they can release inflammatory mediators, promote the occurrence and development of inflammation, and participate in the clearance of pathogens and cell debris at the inflammation site, promote tissue repair and healing process, and can also be polarized into M1 phenotype with pro-inflammatory effect. M1 macrophages can be activated by lipopolysaccharide and other inducers to resist foreign pathogens. Macrophages can also be transformed into M2 phenotype with anti-inflammatory effect, which can produce anti-inflammatory factors to achieve the effect of anti-inflammation. LPS can drive macrophages to polarize to M1 phenotype, while IL-4 can induce macrophages to polarize to M2. M1 macrophages can produce pro-inflammatory responses and produce pro-inflammatory related factors such as IL-6, IL-12 and TNF-alpha. In contrast, M2 macrophages can produce anti-inflammatory responses and repair damaged tissues. In infected tissues, macrophages are first polarized to pro-inflammatory M1 phenotype to help the host resist pathogens. Subsequently, macrophages are polarized to M2 phenotype to form anti-inflammatory responses and repair damaged tissues.
[0004] Plant cells will react to form multivesicular bodies in the paramembranal vesicles between the lipid membrane and the cell wall, and the fusion of the lipid membrane and the cell membrane will lead to the entry of the multivesicular bodies into the extracellular matrix. Multivesicular bodies can participate in cell differentiation, leading to secondary wall thickening. Plant cells secrete exosome-like nanovesicles to participate in intercellular signal transmission and material transport. The exosome-like nanovesicles secreted by plant cells have the characteristics of not being recognized by the immune system due to their special structure and source, which greatly increases their circulation period and bioavailability. Due to their natural source and the presence of special plant lipids, they have certain pharmacological activity. Due to their good biocompatibility, they have certain biological efficiency in in vivo transport and are not recognized and removed by body cells.
[0005] Dendrobium, which belongs to Orchidaceae, has rich pharmacological effects, which is attributed to its diverse chemical components. Currently, the effective chemical components extracted from Dendrobium are mainly polysaccharides, flavonoids, alkaloids and phenolic compounds. Dendrobium polysaccharides can also damage the function of mitochondria by increasing the level of ROS and reducing the level of Matrix Metalloproteinases (MMP), thereby impairing the biosynthesis of Adenosine 5'-triphosphate (ATP), activating the AMPK / mTOR autophagy signal, inducing cancer cell apoptosis, inhibiting cancer cell proliferation, invasion and migration, promoting autophagy and enhancing immune regulation to achieve the anti-tumor effect. SUMMARY
[0006] Therefore, an object of the present application is to provide an application of Dendrobium-derived exosome-like nanovesicles as a product for stimulating macrophages to polarize into M2-type macrophages.
[0007] Another object of the present application is to provide a method for stimulating macrophages to polarize into M2-type macrophages.
[0008] The specific technical solutions adopted by the present application are as follows: In a first aspect, the present application provides an application of Dendrobium-derived exosome-like nanovesicles in the preparation of a product, wherein the function of the product is to stimulate macrophages to polarize into M2-type macrophages.
[0009] Further, the stimulation of macrophages to polarize into M2-type macrophages is manifested in the following aspects: I. reducing the level of ROS in macrophages; II. increasing the content of M2-type macrophages; III. reducing the secretion of pro-inflammatory factors in macrophages; IV. down-regulating the activation of NF-κB pathway by C-type lectin receptor pathway related genes.
[0010] Further, the macrophages include RAW264.7 macrophages.
[0011] Still further, the product up-regulates HIF-1 to promote the activation of cell autophagy, so that the macrophages can remove excess ROS in the body, thereby reducing the level of ROS induced by LPS.
[0012] Further, the pro-inflammatory factors include Eotaxin, Fas L, G-CSF, ICAM-1, IL-12p40, IFN-γ, CXCL9, IL-1a, IL-1b, IL-2, IL-5, IL-6, CXCL1, CCL1, CCL2, CCL3, CCL5, CCL12 and TNF-α.
[0013] In a second aspect, the present application provides a method for stimulating macrophages to polarize into M2 type macrophages, the method comprising adding Dendrobium officinale-derived exosome-like nanovesicles into a culture system of macrophages.
[0014] Further, the concentration of the Dendrobium officinale-derived exosome-like nanovesicles in the culture system is 3-100 μg / mL.
[0015] Further, the culture system is a DEME culture medium containing 2% FBS.
[0016] Further, the time for the Dendrobium officinale-derived exosome-like nanovesicles to stimulate macrophages is 12-24 h.
[0017] The present application has the following beneficial effects: the present application finds that using Dendrobium officinale-derived exosome-like nanovesicles to stimulate macrophages can effectively polarize macrophages into M2 type macrophages. BRIEF DESCRIPTION OF DRAWINGS
[0019] Figure 1 Shown as DONVs characterization figures, wherein: (A) is the particle size; (B) is the Zeta potential; (C) is the TEM image. The TEM image scale is 50 nm; (D) is the lipid analysis.
[0020] Figure 2 Shown as DONVs stability, in vitro uptake and safety studies, wherein: (A, B) are the particle size and Zeta potential stability of DONVs within 25 days; (C) is the flow cytometry detection of uptake. Red is the detection of DIO signal; (D) is the fluorescence microscope to take the uptake. The scale is 100 μm (20x, 40x), 10 μm (100x) (E, F) are the results of in vitro hemolysis experiment; (G) is the CCK8 experiment results, each point represents the mean ± SEM (n = 3).
[0021] Figure 3The pharmacological activity of DONVs was shown, in which: (A) DONVs can reduce the level of LPS-induced ROS; (B) flow cytometry was used to detect M1 macrophage phenotype; (C) flow cytometry was used to detect M2 macrophage phenotype; (D, E) statistical analysis results of B and C; (F) CD30L, GM-CSF, IL-13 expression results, each point represents mean ± SEM (n = 3).
[0022] Figure 4 The expression of pro-inflammatory factors was shown, including Eotaxin, Fas L, G-CSF, ICAM-1, IL-12p40, IFN-γ, CXCL9, IL-1a, IL-1b, IL-2, IL-5, IL-6, CXCL1, CCL1, CCL2, CCL3, CCL5, CCL12 and TNF-α. Each point represents mean ± SEM (n = 3).
[0023] Figure 5 The up-regulated and down-regulated gene related pathways in KEGG pathway enrichment analysis were shown, (A) is the bubble chart of up-regulated gene pathway; (B) is the bubble chart of down-regulated gene pathway; (C) is the column chart of up-regulated gene pathway; (D) is the column chart of down-regulated gene pathway. DETAILED DESCRIPTION
[0025] In order to more clearly illustrate the present application, the present application will be further described below in conjunction with preferred embodiments and drawings. Those skilled in the art should understand that the specific description below is illustrative rather than limiting, and should not limit the protection scope of the present application.
[0026] The materials used in the embodiments, such as those without special instructions, are commonly used in the art and can be obtained commercially. The cell culture conditions in the following examples, such as those without special instructions, are 37°C, 5% CO2, and saturated humidity.
[0027] The reagents and cell sources used in the embodiments of the present application are as follows: Dendrobium candidum was from Dendrobium Cultivation Base in Jinshan Village, Daqing Town, Yueqing City, Zhejiang Province (Yueqing, Zhejiang, China). Sucrose was from Servicebio (Wuhan, Hubei, China). BCA assay kit was purchased from BOSTER Biological Co., Ltd. (Wuhan, Hubei, China). PBS, DMSO, DAPI, 4% paraformaldehyde, DCFH-DA reactive oxygen fluorescence probe were purchased from Solabio Technology Co., Ltd. (Beijing, China). DIO was from Shanghai Biyun Tian Biological Technology Co., Ltd. CCK8 kit was from Meilunbio Biotechnology Co., Ltd. (Dalian, Liaoning, China). Lipopolysaccharide LPS was from Yuan Ye Biotechnology Co., Ltd. (Shanghai, China). DMEM medium, fetal bovine serum were from Gibco (Waltham, MA, USA). Intracellular Staining Perm Wash Buffer, PE anti-mouse F4 / 80 Recombinant, PE-Cyanine anti-mouse CD86, APC anti-mouse CD206 were from Biolegend (San Diego, CA, USA). RAW264.7 macrophages were from Guangzhou Sike Biological Technology Co., Ltd. Mouse monocyte macrophage leukemia cell line RAW264.7 (Guangzhou, Guangdong, China).
[0028] Example 1 Extracellular vesicle-like nanovesicles (DONVs) from Dendrobium candidum were extracted by ultracentrifugation-sucrose concentration gradient centrifugation method: Fresh Dendrobium candidum was washed, cut into sections, and crushed. PBS buffer was added to cover the Dendrobium candidum fragments, which were then placed in a juicer to extract juice. The filtered juice was collected, centrifuged at 4°C and 3000g for 30 min, the supernatant was taken, and centrifuged at 4°C and 10000g for 90 min. The supernatant was filtered through a 0.45μm filter. The filtrate was centrifuged at 4°C and 150000g for 2.5h, the supernatant was discarded, and 8mL of 60% sucrose solution, 8mL of 45% sucrose solution and 8mL of 30% sucrose solution were sequentially added from bottom to top to form layers. About 7mL of 8% sucrose solution was added to the uppermost layer, and centrifuged at 4°C and 150000g for 1.5h. The band between 30% and 45% sucrose was aspirated, and the above steps were repeated at 4°C and 150000g for 1.5h. The supernatant was discarded, and 800μL of PBS buffer was added to resuspend the suspension. The suspension was DONVs, which were stored at -80°C.
[0029] The particle size, Zeta potential and NTA concentration of DONVs were measured by dynamic light scattering method. TEM was entrusted to Beijing Zhongke Bai Cuo Technology Co., Ltd. The results are as follows: Results are as follows: Figure 1 A, Figure 1The particle size of the DONVs was 141 nm, the average potential was -20 V, and the DONVs were negatively charged, as shown in FIG. B. The morphology of the DONVs was observed using a TEM transmission electron microscope, and the results are shown in FIG. C. Figure 1 As shown in FIG. C, the DONVs had an ellipsoidal vesicle structure with a membrane structure and an empty cavity structure inside.
[0030] The lipid components in the extracted DONVs were analyzed by LC-MS / MS. The results are shown in FIG. D. Figure 1 As shown in FIG. D, the main components contained in the DONVs were triglycerides (TG, 55.39%), hexosyl ceramide (Hex1Cer, 12.13%), phosphatidic acid (PA, 7.35%), digalactosyl diglyceride (DGDG, 2.10%), and diglyceride (DG, 7.53%).
[0031] The particle size and Zeta potential of the DONVs were detected (dynamic light scattering method) within 25 days at 4°C. The results are shown in FIG. A and FIG. B. Figure 2 As shown in FIG. A and FIG. B, within 25 days, the particle size ranged from 130 nm to 165.5 nm, and the Zeta potential ranged from -5 V to -20 V. The change in particle size did not exceed 15% of the particle size itself, and the Zeta potential range was all negative. It can be seen that the DONVs are relatively stable under the storage condition of 4°C, and no aggregation, dispersion, or other phenomena occur. The particle dispersion system is negatively charged.
[0032] Example 2 Logarithmic growth phase RAW264.7 cells were collected, and the culture medium was discarded. The cells were infiltrated with PBS, centrifuged at 800 rpm for 3 min, the supernatant was discarded, and DMEM was added for resuspension. 10 μL of the cell suspension was taken for counting, and the cell number was adjusted to 1×10 4 The cell number was adjusted to 1×10
[0033] The DONVs were incubated with RAW 264.7 macrophages for 12 h, and the uptake of the DONVs by the macrophages was observed under an inverted fluorescence microscope. As shown in Figure 2 As shown in A, no green fluorescence appeared in the control group, but green fluorescence appeared after the addition of DIO-DONVs in the experimental group. Under high magnification, green fluorescence appeared in the cells, indicating that the DONVs could be taken up by RAW 264.7 macrophages. As shown in Figure 2 As shown in C, flow cytometry analysis showed that the fluorescence in the FITC channel increased by 93.8% after 12 h of treatment with DIO-DONVs, indicating that fluorescence expression appeared in the cells after treatment with DIO-DONVs, As shown in Figure 2 As shown in D, green fluorescence appeared around the nucleus of RAW264.7 macrophages after 12 h of treatment with DIO-DONVs, proving that the DONVs were taken up by RAW264.7 macrophages.
[0034] Fresh blood (2 mL) was collected from KM mice by the eyeball blood collection method into a blood collection tube treated with the anticoagulant heparin, and centrifuged at 1500 rpm for 10 min. The supernatant was discarded, and the cells were resuspended in PBS. The above steps were repeated until the supernatant was clear. The supernatant was discarded, and 1 mL of the red blood cell suspension was mixed with 9 mL of PBS to prepare a 10% red blood cell suspension. According to the experimental concentration gradient, 450 μL of the 10% red blood cell suspension was added to 50 μL of DONVs at 200 μg / mL, 100 μg / mL, 50 μg / mL, 25 μg / mL, 12.5 μg / mL, 6.25 μg / mL, 3.125 μg / mL, and 1.5625 μg / mL, respectively. After mixing, the mixture was incubated at 37°C for 3 h.
[0035] As shown in Figure 2 As shown in E, compared with the positive control group, no red blood cell hemolysis occurred in the different concentrations of DONVs, As shown in Figure 2 As shown in F, the hemolysis rates of the different concentrations of DONVs were all less than 0.4% (hemolysis efficiency = OD450 nm (experimental group) / OD450 nm (positive control group) x 100%), indicating that DONVs did not produce hemolysis at the in vitro level and had biological safety.
[0036] As shown in Figure 2 As shown in G, the in vitro cytotoxicity of different concentrations of DONVs on RAW264.7 macrophages, after incubation of DONVs with RAW264.7 macrophages for 24 h, the survival rates of cells treated with different concentrations of DONVs were all greater than 85%, therefore DONVs did not exhibit cytotoxicity on RAW264.7 macrophages.
[0037] Example 3 RAW264.7 cells in logarithmic growth phase were collected and the culture medium was discarded. The cells were infiltrated with PBS and centrifuged at 800 rpm for 3 min. The supernatant was discarded, and the cells were resuspended in DMEM. 10 μL of the cell suspension was taken for counting, and the cell concentration was adjusted to 1 × 10 6 The cells were cultured overnight in a 6-well cell culture plate, and DONVs were added to the experimental wells for incubation for 24 h. The cell supernatant was removed, and the cells were blown off. The cells were centrifuged at 350 g for 5 min. The cells were washed twice with PBS containing 1% FBS, and the supernatant was discarded. The cells were resuspended in 100 μL of 5% BSA, and the cells were blocked at room temperature for 30 min. 1.25 μL of PE anti-mouse F4 / 80 recombinant and 1.75 μL of PE-Cyanine anti-mouse CD86 antibody were added, and the cells were incubated at 4°C in the dark for 30 min. The cells were centrifuged at 350 g for 5 min, washed twice with PBS containing 1% FBS, fixed with 4% polyformaldehyde at room temperature in the dark for 20 min, centrifuged at 350 g for 5 min, and the supernatant was discarded. The cells were washed twice with PBS containing 1% FBS, resuspended in 300 μL of PBS, and subjected to flow cytometry detection. The results are shown in Figs. Figure 3 As shown in Fig. A, DONVs successfully reduced the level of ROS produced by LPS-induced RAW264.7 macrophages.
[0038] RAW264.7 macrophages in logarithmic growth phase were collected, and the culture medium was discarded. The cells were infiltrated with PBS and centrifuged at 800 rpm for 3 min. The supernatant was discarded, and the cells were resuspended in DMEM. 10 μL of the cell suspension was taken for counting, and the cell concentration was adjusted to 1 × 10 5 The cells were cultured overnight in a 6-well cell culture plate, and DONVs were added to the experimental wells for incubation for 24 h. The cell supernatant was removed, and the cells were blown off. The cells were centrifuged at 350 g for 5 min. The cells were washed twice with PBS containing 1% FBS, and the supernatant was discarded. The cells were resuspended in 100 μL of 5% BSA, and the cells were blocked at room temperature for 30 min. 1.25 μL of PE anti-mouse F4 / 80 recombinant and 1.75 μL of PE-Cyanine anti-mouse CD86 antibody were added, and the cells were incubated at 4°C in the dark for 30 min. The cells were centrifuged at 350 g for 5 min, washed twice with PBS containing 1% FBS, fixed with 4% polyformaldehyde at room temperature in the dark for 20 min, centrifuged at 350 g for 5 min, and the supernatant was discarded. The cells were washed twice with PBS containing 1% FBS, resuspended in 300 μL of PBS, and subjected to flow cytometry detection. The results are shown in Figs. Figure 3 A, Figure 3 As shown in Figs. B and C, after DONVs were co-incubated with LPS-induced RAW264.7 macrophages for 24 h, the content of M1 macrophage polarization molecule F4 / 80+CD86+ decreased by 10.6% ± 1.55% compared with the positive control group of LPS-induced RAW264.7. Figure 3 C, Figure 3 As shown in Figs. D and E, the content of M2 macrophage polarization molecule F4 / 80+CD206+ increased by 11.91% ± 0.21%.
[0039] As shown in Figure 3 E, after co-incubation with DONVs, the content of CD30L was detected by ELISA, and the results showed that the content of CD30L increased by 534.21±17.65 pg / mL, indicating that DONVs can mediate the activation of NF-κB signal transduction pathway. As shown in Figure 3 F, after co-incubation with DONVs, the content of GM-CSF decreased by 7145.18±455.97 pg / mL, indicating that DONVs can inhibit the induction of macrophages into M1 type. IL-13 in macrophages can promote the polarization of M2 type macrophages. After co-incubation with DONVs, the content of IL-13 decreased by 265.73±413.93 pg / mL, indicating that DONVs can promote the induction of macrophages into M2 type, further indicating that DONVs can mediate the activation of NF-κB signal transduction pathway, so that the M1 / M2 ratio of RAW264.7 macrophages decreases, and M1 type macrophages are transformed into M2 type macrophages.
[0040] Example 4 Logarithmic growth phase RAW264.7 macrophages were collected, and the culture medium was discarded. PBS was added to infiltrate the cells, centrifuged at 800 rpm for 3 min, the supernatant was discarded, and DMEM was added for resuspension. 10 μL of cell suspension was taken for counting, and the cell concentration was adjusted to 1×106 / mL, and added to a 6-well cell culture plate. About 2 mL of cell suspension per well was cultured overnight, and 25 μg / mL of DONVs was added to the incubation for 24 h in the experimental group, and a control group (without the addition of DONVs) was set. The cell supernatant was aspirated and the cells were blown off, centrifuged at 800 rpm for 3 min, and the cell supernatant was taken and stored at -80°C to avoid repeated freezing and thawing. The slides were taken out of the box and equilibrated at room temperature for 30 min, and the chip was placed at room temperature for 2 h. 100 μL of sample diluent was added, incubated at room temperature on a shaking bed for 1 h, and the buffer in each well was removed and 80 μL of sample was added. The standard and sample in each well were removed, washed with washing solution for 10 times, 10 s each time, and the antibody mixture tube was centrifuged. 1.4 mL of sample diluent was added, mixed uniformly and centrifuged. 80 μL of Cy3-streptavidin was added to each well, and incubated at room temperature on a shaking bed for 1 h in the dark. The washing solution was washed for 10 times, 10 s each time, and the Cy3-streptavidin was centrifuged. The washing solution was washed for 5 times, 5 min each time, the slide frame was removed, and the signal was scanned by a laser scanner. Cy3 or green channel (excitation frequency = 532 nm) was used for detection. GSM-INF-3 data analysis software was used for data analysis, and the results are shown in Figure 4As shown, after the inflammatory response induced by LPS, after co-incubation with DONVs, the content of pro-inflammatory factor Eotaxin decreased by 53.37±23.84 pg / mL; the content of Fas L decreased by 1359.68±73.87 pg / mL; the content of G-CSF decreased by 12910.83±6624.82 pg / mL; the content of ICAM-1 decreased by 3736.15±322.90 pg / mL; the content of IL-12p40 decreased by 419.97±7.60 pg / mL; the content of IFN-γ decreased by 1416.13±130.93 pg / mL; the content of CXCL9 decreased by 681.08±4.38 pg / mL; the contents of pro-inflammatory factors IL-1a, IL-1b, IL-2, IL-5, IL-6 decreased by 23519.37±920.26, 503.80±34.06, 1229.92±131.64, 1775.87±145.22, 17423.10±983.26 pg / mL, respectively; the content of CXCL1 decreased by 1065.84±9.66 pg / mL; the contents of CCL1, CCL2, CCL3, CCL5, CCL12 decreased by 1775.51±215.62, 966.98±1.98, 27193.66±1953.82, 83149.05±3600.84, 50647.42±1691.19 pg / mL, respectively; the content of TNF-α decreased by 130613.28±15846.81 pg / mL, and the decrease in the contents of the above anti-inflammatory factors indicates that DONVs can reduce the production of inflammatory factors induced by LPS, thereby exhibiting an anti-inflammatory effect at the in vitro level.
[0041] Example 5 Logarithmic growth period RAW264.7 macrophages were collected, and the culture medium was discarded. PBS was added to infiltrate the cells, which were centrifuged at 800 rpm for 3 min, and the supernatant was discarded. DMEM was added for resuspension, 10 μL of the cell suspension was taken for counting, the cell concentration was adjusted to 1×10 6 μL / mL, and was added to a 6-well cell culture plate. 2 mL of the cell suspension was added for overnight culture, and DONVs with a concentration of 25 μg / mL were added to the experimental wells for incubation for 24 h. At the same time, a control group (without the addition of DONVs) was set, the cell supernatant was taken, the cells were blown off, centrifuged at 800 rpm for 3 min, resuspended with DMEM, and machine detection was performed. Sequencing was performed using a Huada high-throughput sequencing platform; each cell was measured for ≥50,000 reads.
[0042] By comparing the sequencing data of the experimental group and the control group, the results are shown in Table 1: Table 1 Expression gene type In single-cell sequencing, 17386 macrophage expression genes were found in the experimental group and 12110 macrophage expression genes were found in the control group. After clustering analysis using UMAP algorithm, each cluster identified after clustering analysis of the two groups was subjected to differential gene identification, and t-distributed neighborhood embedding algorithm (t-SNE) dimension reduction algorithm was used to effectively project large data sets into two or three dimensions, so that similar cells were clustered together. Based on the t-SNE typing results, specific labeling was performed for the key marker genes, and the expression of individual marker genes in each cluster was obtained. The log10(UMI+1) value was normalized and clustered. The results are as follows Figure 5 As shown in A, in KEGG pathway enrichment analysis, 8 up-regulated genes related to macrophage pathways and 7 down-regulated genes related to macrophage pathways were screened after DONVs treatment.
[0043] The results show that DONVs can change the HIF-1, autophagy and ROS related pathways at the same time, and it is inferred that DONVs can activate autophagy by up-regulating HIF-1, so that RAW264.7 can clear excess ROS in the body, thereby reducing the level of ROS induced by LPS.
[0044] At the same time, according to the screening of KEGG enrichment pathway, it is found that the up-regulated genes also participate in the NF-κB pathway, and the down-regulated genes also participate in the C-type lectin receptor pathway. The results of differential gene labeling show that DONVs can down-regulate the genes related to the C-type lectin receptor pathway, thereby activating the NF-κB pathway. DONVs can activate the NF-κB pathway by down-regulating the genes related to the C-type lectin receptor pathway, thereby reducing the ratio of M1 / M2 macrophages.
[0045] Although the above embodiments have been described, those skilled in the art can make further changes and modifications to the embodiments once they know the basic creative concept, so the above description is only an embodiment of the present application and does not limit the patent protection scope of the present application. Any equivalent structure or equivalent process transformation using the content of the present application specification and drawings, or direct or indirect application in other related technical fields, is also included in the patent protection scope of the present application.
Claims
1. The use of exosome-like nanovesicles derived from Dendrobium candidum in the preparation of a product, characterized in that, The product functions to stimulate macrophages to polarize into M2 type macrophages.
2. Use according to claim 1, characterized in that, The stimulation of macrophages to polarize into M2 type macrophages is manifested as I, II, III and IV: I, reducing the ROS level in macrophages; II, increasing the content of M2 type macrophages; III, reducing the secretion of pro-inflammatory factors in macrophages; IV, down-regulating the activation of C-type lectin receptor pathway related genes to NF-κB pathway.
3. Use according to claim 1, characterized in that, The macrophages are RAW264.7 macrophages.
4. Use according to claim 2, characterized in that, The product reduces the ROS level induced by LPS by up-regulating HIF-1 to activate autophagy and make macrophages remove excess ROS in the body.
5. Use according to claim 2, characterized in that, The pro-inflammatory factors include Eotaxin, Fas L, G-CSF, ICAM-1, IL-12p40, IFN-γ, CXCL9, IL-1a, IL-1b, IL-2, IL-5, IL-6, CXCL1, CCL1, CCL2, CCL3, CCL5, CCL12 and TNF-α.
6. A method of stimulating polarization of macrophages to M2-type macrophages, characterized by, The method comprises adding Dendrobium candidum derived exosome-like nanovesicles into a culture system of macrophages.
7. The method of claim 6, wherein, The concentration of the Dendrobium candidum derived exosome-like nanovesicles in the culture system is 3-100 μg / mL.
8. The method of claim 6, wherein, The culture system is DEME culture medium containing 2% FBS.
9. The method of claim 6, wherein, The time for the Dendrobium candidum derived exosome-like nanovesicles to stimulate macrophages is 12-24 h.
